CAS 1035688-66-4

Farudodstat

CAS: 1035688-66-4

Farudodstat (ASLAN003) is an orally active and potent inhibitor of DHODH with antitumor activity. It has the potential to be a first-in-class candidate in AML.

Formula: C₁₉H₁₄F₂N₂O₃

Purity: 98.36%

Color and Shape: Solid

Molecular weight: 356.32

Ref: TM-T10384

Aslan003

CAS: 1035688-66-4

Formula: C₁₉H₁₄F₂N₂O₃

Purity: 97%

Color and Shape: Solid

Molecular weight: 356.3229

Ref: IN-DA01LIBF

Farudodstat

CAS: 1035688-66-4

Farudodstat

Purity: ≥98%

Molecular weight: 356.32g/mol

Ref: 54-BUP06604

2-[(3,5-Difluoro-3'-Methoxy-1,1'-Biphenyl-4-Yl)Amino]Nicotinic Acid

CAS: 1035688-66-4

2-[(3,5-Difluoro-3'-Methoxy-1,1'-Biphenyl-4-Yl)Amino]Nicotinic Acid

Purity: 97%

Molecular weight: 356.32g/mol

Ref: 54-PC108854

ASLAN003

CAS: 1035688-66-4

ASLAN003 is a biological product that can be used in the treatment of eye disorders and cancer. ASLAN003 is an antibody that binds to CD20, which is a protein found on the surface of B-cells. When ASLAN003 binds to CD20, it inhibits the growth of B-cells and reduces their viability. This inhibition leads to an increase in the number of myeloid leukemia cells and decreases their diameter, as well as increased phagocytosis by macrophages. The pharmacokinetic properties of ASLAN003 have been studied in humans with solid tumours and myeloid leukemia cell lines. It has been shown that this drug has a long half-life and low clearance rate, allowing for effective pharmacological treatment. Although there are no studies investigating its effects on hematopoietic cells or autoimmune diseases, ASLAN003 has shown potential benefits in these areas as well.

Formula: C₁₉H₁₄F₂N₂O₃

Purity: Min. 95%

Molecular weight: 356.3 g/mol

Ref: 3D-KRB68866